Popular Articles

JHPIEGO's Dr. Harshad Sanghvi Receives International Health Award - Global Health Council Present Award For Best Practices In Global Health On May 28
Jhpiego, an international non-profit health organization affiliated with Johns Hopkins University, is pleased to announce that Dr. Harshad Sanghvi, Vice President and Medical Director of Jhpiego, has been awarded the 2009 Award for Best Practices in Global Health from the Global Health Council.

Evaluating The ADHD Medication VYVANSE CII Demonstrated No Change In Pharmacokinetic Profile Of VYVANSE When Coadministered With Prilosec OTC 40 Mg
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE® (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC® 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated. In the same study, coadministration of Prilosec OTC with ADDERALL XR resulted in a nearly 45 percent reduction in the median time to reach maximum plasma concentrations of amphetamine, the active medication. Other pharmacokinetic parameters (maximum plasma concentration and area under curve) of active medication were not altered for either VYVANSE or ADDERALL XR when coadministered with Prilosec OTC. This study, which is the first to evaluate the pharmacokinetics of VYVANSE and ADDERALL XR taken alone and with Prilosec OTC 40 mg, was recently presented at the International Congress on Clinical Pharmacy, co-sponsored by the American College of Clinical Pharmacy (ACCP), in Orlando, FL.
News of the day
BioPartners GmbH Withdraws Its Application For Biferonex (interferon Beta-1a)
The European Medicines Agency has been formally notified by BioPartners GmbH of its decision to withdraw its application for Biferonex (interferon beta-1a), 6 million-international-unit solution for injection, prefilled syringes for subcutaneous administration.
Oncology

Multi-Agency Working Needed To Tackle 'Worryingly High' Prison Deaths

Mental health care must improve to halt the staggering number of suicides occurring in prisons, new research has revealed. In 2008, there were 91 suicides per 100,000 per year in England and Wales in the prison population, compared with 8.5 per 100,000 in the general population. Now a new three year study has found that a large proportion of those entering prison are already "vulnerable" with self harm, alcohol misuse and psychiatric issues. The National Case-Control Study of Self-inflicted Death in Prisons in England and Wales collected data based on 220 prisoner records and feedback from prison and healthcare staff. Men accounted for 95 per cent of the deaths, the research conducted by Professor Jenny Shaw, at Northwest Forensic Academic Network and The University of Manchester and colleagues found. Professor Shaw presented the research findings today at the Annual Meeting of the Royal College of Psychiatrists in Liverpool. Hanging was chosen as the method of death by 90%. Alarmingly, over a third (35%) of deaths happened within the first month in prison and departed prisoners were three times more likely to have had no visits during the prison term. They were also six times more likely to have a history of self-harm and twice as likely to have a history of alcohol misuse problems. The findings have prompted calls for multi-agency working between prison officers, doctors and mental health professionals. According to Professor Shaw "imported vulnerability" where prisoners enter the system with psychiatric diagnosis, self harm history, alcohol misuse problems and mental health contact is "very common" in the general prison population. "To reduce the risk we need to improve the general mental health care of all prisoners," Professor Shaw said. "We need to include the kinds of methods we have in the community but adapted for prisons. Because of the nature of the place you have to adjust what you do and address the fact they are locked up for most of the day and are in a custodial regime. We need models that work for the socially excluded people at a primary care level, including prison officers in training." Professor Shaw also urged better exchange of information between the prison service and outside agencies and called for an improvement in the assessment and monitoring procedures for those at risk. Extra care should also be provided at time of key risk, Professor Shaw said. Reference: Annual Meeting of the Royal College of Psychiatrists, BT Convention Centre, Liverpool, 2 -5 June 2009 Royal College of Psychiatrists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):